Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke | Zendy

Shumei Man | Zendy; Ying Xian | Zendy; DaJuanicia N. Holmes | Zendy; Roland Matsouaka | Zendy; Jeffrey L. Saver | Zendy; Eric E. Smith | Zendy; Deepak L. Bhatt | Zendy; Lee H. Schwamm | Zendy; Gregg C. Fonarow | Zendy

Open Access

Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke

Author(s) -

Shumei Man,

Ying Xian,

DaJuanicia N. Holmes,

Roland Matsouaka,

Jeffrey L. Saver,

Eric E. Smith,

Deepak L. Bhatt,

Lee H. Schwamm,

Gregg C. Fonarow

Publication year - 2020

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2020.5697

Subject(s) - medicine , interquartile range , stroke (engine) , retrospective cohort study , thrombolysis , emergency medicine , ischemic stroke , tissue plasminogen activator , cohort , acute stroke , ischemia , myocardial infarction , mechanical engineering , engineering

Earlier administration of intravenous tissue plasminogen activator (tPA) in acute ischemic stroke is associated with reduced mortality by the time of hospital discharge and better functional outcomes at 3 months. However, it remains unclear whether shorter door-to-needle times translate into better long-term outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research